Zimmer Holdings Inc. (ZMH) is scheduled to report its third-quarter 2014 results ... show that Zimmer is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1, 2 or …
ZMH) from Buy to Hold. The analyst expects uncertainty regarding the company's performance to persist for the next several quarters, which would keep the stock range bound, at best. Zimmer Holdings announced on Wednesday that it …
The Federal Trade Commission (FTC) is already in chambers considering the Zimmer Holdings Inc. (NYSE: ZMH) $13.35 billion deal to merge with ... The Thomson/First Call price target for the stock is $26.88. Globus closed Wednesday at …
Zimmer Holdings (NYSE: ZMH) has agreed with the European Commission (the "EC ... Zimmer will acquire Biomet in a cash and stock transaction valued at approximately $13.35 billion, including the assumption of net debt.
Zimmer Holdings Inc. (ZMH) is scheduled to report its fourth-quarter 2014 results ... show that Zimmer is likely to beat earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1, 2 or 3 …
Company Ticker Return Value (Millions) GENERAL MOTORS CO GM -1.1% 70 COVIDIEN PLC COV 11.1% 68 DIRECTV GROUP INC DTV 8.9% 67 MARKET VECTORS GOLD MINERS GDX -9.3% 46 ZIMMER HOLDINGS INC ZMH 12.9% …
Dear LD: You have an excellent memory. Yes, Amgen and Biomet were two of those recommendations. Biomet was just acquired by Zimmer Holdings (ZMH). I remember those stocks well because my sister, who put $2,000 in each, enjoys …
Goldman Sachs is out with a research report this morning, where it upgraded shares of Zimmer Holdings Inc. (NYSE: ZMH) to Buy, from Neutral; it has a $75.00 price target on the stock. The GS analysts said, “We upgrade ZMH to Buy from …
In Thursday's regular trading session, ZMH is currently trading at $52.80, down $0.17 or 0.32% on a volume of 2.98 million shares. In the past 52 weeks, the stock has traded in a range of $41.79-$64.77.
Zimmer Holdings (NYSE: ZMH) announced that it has proposed a remedy package to ... Zimmer will acquire Biomet in a cash and stock transaction valued at approximately $13.35 billion, including the assumption of net debt.